Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy-Reference-Cited by-同舟云学术

Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy

Published:2013-11-22 Issue:12 Volume:28 Page:1849-1858
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Su Chien-Wei¹²³,Wu Chun-Ying²⁴⁵⁶,Hung Hung-Hsu²³⁷,Wu Chu-Hui⁸,Sheen I-Jane³,Wu Jaw-Ching³⁸

Affiliation:

1. Division of Gastroenterology; Department of Medicine; Taipei Veterans General Hospital; Taipei Taiwan

2. Faculty of Medicine; National Yang-Ming University; Taipei Taiwan

3. Institute of Clinical Medicine; School of Medicine; National Yang-Ming University; Taipei Taiwan

4. Division of Gastroenterology; Taichung Veterans General Hospital; Taichung Taiwan

5. Department of Public Health and Graduate Institute of Clinical Medicine; China Medical University; Taichung Taiwan

6. Department of Life Sciences; National Chung-Hsing University; Taichung Taiwan

7. Division of Gastroenterology; Department of Medicine; Cheng Hsin General Hospital; Taipei Taiwan

8. Department of Medical Research and Education; Taipei Veterans General Hospital; Taipei Taiwan

Funder

National Science Council of Taiwan

Taipei Veterans General Hospital

Yang-Ming University

Center of Excellence for Cancer Research at TVGH

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12283/fullpdf

Reference33 articles.

1. Hepatitis B virus infection;Liaw;Lancet,2009

2. Chronic hepatitis B;Lok;Hepatology,2007

3. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection;Yang;J. Clin. Oncol.,2010

4. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients;Su;Gastroenterology,2006

5. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma;Kao;Liver Int.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial;Evidence-Based Complementary and Alternative Medicine;2022-03-25

2. Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B;PLOS ONE;2019-08-30

3. Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients;Journal of the American College of Surgeons;2018-06

4. Impact of etiological treatment on prognosis;Hepatology International;2017-07-12

5. On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B;PLOS ONE;2017-03-28